HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$435.01
Day range
$424.20 - $437.00
Year range
$265.00 - $614.36
Market cap
9.93B USD
Avg Volume
371.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 321.08M | 210.77% |
Operating expense | 356.24M | 113.48% |
Net income | -58.58M | 1.42% |
Net profit margin | -18.24 | 68.28% |
Earnings per share | -2.57 | 5.17% |
EBITDA | -59.22M | 11.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 983.56M | 6.19% |
Total assets | 1.26B | 20.85% |
Total liabilities | 656.90M | 128.20% |
Total equity | 602.69M | — |
Shares outstanding | 22.94M | — |
Price to book | 16.48 | — |
Return on assets | -11.37% | — |
Return on capital | -15.50% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -58.58M | 1.42% |
Cash from operations | -133.46M | -27.73% |
Cash from investing | 27.58M | 157.52% |
Cash from financing | 8.96M | -54.70% |
Net change in cash | -96.91M | 26.95% |
Free cash flow | -120.19M | -58.05% |
About
Founded
2011
Headquarters
Website
Employees
915
